ArticleJournal of diabetes investigation2026
Close relationship between β2-microglobulin and type 2 diabetes-associated peripheral neuropathy.
Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
AIMS/
introductionThis study aimed to elucidate the correlation between β2-microglobulin (β2-MG) and peripheral neuropathy in type 2 diabetes mellitus (T2DM). MATERIALS AND
methodsDiabetic peripheral neuropathy (DPN) was defined on the nerve conduction study (NCS). The general information and relevant clinical data of patients with T2DM were retrospectively analyzed using logistic regression to identify independent risk factors. The discriminative ability of individual and combined risk factors was evaluated using the area under the receiver operating characteristic curve (AUC).
resultsA total of 1,219 patients with T2DM who received medical care at Dongyang People's Hospital between January 2023 and December 2023 were included in this study. Of the 954 patients with abnormal NCS findings, 899 exhibited sensory abnormalities, whereas 492 exhibited motor abnormalities. Multivariate analysis showed that DPN was positively correlated with age (P < 0.001), β2-MG (P = 0.022), uric acid (P = 0.028), and male sex (P < 0.001), but negatively correlated with albumin (P < 0.001). The combined discriminative power of these risk factors was 0.754, with β2-MG showing the highest individual diagnostic performance (AUC = 0.710).
conclusionsT2DM patients with advanced age, elevated β2-MG and uric acid levels, and hypoalbuminemia have higher DPN possibilities; follow-up confirmation with NCS may facilitate the early diagnosis and management of peripheral neuropathy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.